Skip to content

The safety and effectiveness of triamcinolone acetonide-filling and oral prednisone method in preventing stenosis after extensive esophageal endoscopic submucosal dissection

The safety and effectiveness of triamcinolone acetonide-filling and oral prednisone method in preventing stenosis after extensive esophageal endoscopic submucosal dissection

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200063376
Enrollment
Unknown
Registered
2022-09-05
Start date
2022-09-05
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal superficial cancer and precancerous lesion

Interventions

TAFOP group:triamcinolone acetonide-filling and oral prednisone after ESD
ELSI group:local injection of triamcinolone acetonide and oral prednisone after ESD

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. early esophageal cancer limited to the mucosal layer or precancerous lesion; 2. eligible for ESD and expected mucosal defect involving >= 75% circumference; 3. no lymph node metastasis on endoscopic ultrasonography and computed tomography.

Exclusion criteria

Exclusion criteria: 1. local recurrence after previous treatment; 2. contraindications for ESD, anesthesia, and long-term steroid use ; 3. presence of a swallowing disorder or serious infectious disease of the head and neck; 4. patient desire for additional surgical treatment for non-curative endoscopic resection before complete re-epithelialization.

Design outcomes

Primary

MeasureTime frame
incidence of stenosis;total number of endoscopic balloon/bougie dilatation procedures;

Secondary

MeasureTime frame
total number of additional TA-filling procedures;time to initial stenosis;time to complete re-epithelialization without stenosis;dysphagia score;

Countries

China

Contacts

Public ContactLong Rong

Peking University First Hospital

ronglong8@vip.sina.com+86 10 83572437

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026